DSK Co., Ltd. (KOSDAQ:109740)
4,235.00
-30.00 (-0.70%)
At close: Sep 11, 2026
DSK Co., Ltd. Revenue
DSK Co., Ltd. had revenue of 6.43B KRW in the quarter ending June 30, 2026, a decrease of -79.16%. This brings the company's revenue in the last twelve months to 20.56B, down -51.84% year-over-year. In the year 2025, DSK Co., Ltd. had annual revenue of 43.18B with 90.72% growth.
Revenue (ttm)
20.56B
Revenue Growth
-51.84%
P/S Ratio
5.16
Revenue / Employee
186.89M
Employees
110
Market Cap
106.10B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 43.18B | 20.54B | 90.72% |
| Dec 31, 2024 | 22.64B | -48.86B | -68.34% |
| Dec 31, 2023 | 71.50B | 23.27B | 48.24% |
| Dec 31, 2022 | 48.23B | -1.56B | -3.13% |
| Dec 31, 2021 | 49.79B | 17.20B | 52.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Dong A Eltek | 441.80B |
| Keeps Biopharma | 220.48B |
| Osung Advanced Materials | 168.90B |
| C&G Hi Tech | 165.57B |
| Rorze Systems | 145.33B |
| Viatron Technologies | 57.75B |
| FNS TECH. | 57.71B |
| AUROS Technology | 39.57B |